Acceder Registro /

Johnny Di Pierdomenico

Buscador

Miralles de Imperial-Ollero JA, Gallego-Ortega A, Norte-Munoz M, Di Pierdomenico J, Bernal-Garro JM, Valiente-Soriano FJ, Vidal-Sanz M. Short- and Long-Term Study of the Impact of Focal Blue Light-Emitting Diode-Induced Phototoxicity in Adult Albino Rats. Int J Mol Sci. 2021 Sep 9;22(18):9742. doi: 10.3390/ijms22189742. PubMed PMID: 34575905; PubMed Central PMCID: PMC8466789.
AÑO: 2021; IF: 6.208
Autores:
Miralles de Imperial-Ollero JA, Gallego-Ortega A, Norte-Munoz M, Di Pierdomenico J, Valiente-Soriano FJ, Vidal-Sanz M. An in vivo model of focal light emitting diode-induced cone photoreceptor phototoxicity in adult pigmented mice: Protection with bFGF. Exp Eye Res. 2021 Oct;211:108746. doi: 10.1016/j.exer.2021.108746. Epub 2021 Aug 24. PubMed PMID: 34450185.
AÑO: 2021; IF: 3.77
Autores:
Vidal-Villegas B, Di Pierdomenico J, Gallego-Ortega A, Galindo-Romero C, Martinez-de-la-Casa JM, Garcia-Feijoo J, Villegas-Perez MP, Vidal-Sanz M. Systemic treatment with 7,8-Dihydroxiflavone activates TtkB and affords protection of two different retinal ganglion cell populations against axotomy in adult rats. Exp Eye Res. 2021 Sep;210:108694. doi: 10.1016/j.exer.2021.108694. Epub 2021 Jul 8. PubMed PMID: 34245756.
AÑO: 2021; IF: 3.77
Garcia-Ayuso D, Di Pierdomenico J, Garcia-Bernal D, Vidal-Sanz M, Villegas-Perez MP. Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations. Neural Regen Res. 2022 Sep;17(9):1937-1944. doi: 10.4103/1673-5374.335692. PubMed PMID: 35142670; PubMed Central PMCID: PMC8848608.
AÑO: 2022; IF: 6.1
Di Pierdomenico J, Gallego-Ortega A, Martinez-Vacas A, Garcia-Bernal D, Vidal-Sanz M, Villegas-Perez MP, Garcia-Ayuso D. Intravitreal and subretinal syngeneic bone marrow mononuclear stem cell transplantation improves photoreceptor survival but does not ameliorate retinal function in two rat models of retinal degeneration. Acta Ophthalmol. 2022 Sep;100(6):e1313-e1331. doi: 10.1111/aos.15165. Epub 2022 May 5. PubMed PMID: 35514078.
AÑO: 2022; IF: 3.4
Autores:

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R